| Primary |
| Product Used For Unknown Indication |
52.9% |
| Sensory Disturbance |
5.8% |
| Vomiting |
5.8% |
| Uterine Neoplasm |
4.1% |
| Acute Myeloid Leukaemia |
3.3% |
| Breast Cancer |
3.3% |
| Oesophageal Neoplasm |
3.3% |
| Postoperative Analgesia |
3.3% |
| Prophylaxis Of Nausea And Vomiting |
3.3% |
| Nausea |
2.5% |
| Neoplasm Malignant |
2.5% |
| Pancreatic Carcinoma |
2.5% |
| Analgesic Therapy |
1.7% |
| Chemotherapy |
1.7% |
| Acute Lymphocytic Leukaemia |
0.8% |
| Chronic Myelomonocytic Leukaemia |
0.8% |
| Myelodysplastic Syndrome |
0.8% |
| Urethral Operation |
0.8% |
| Uterine Cancer |
0.8% |
|
| Anaemia Haemolytic Autoimmune |
8.3% |
| Convulsion |
8.3% |
| Dyspnoea |
8.3% |
| Megacolon |
8.3% |
| Blood Pressure Decreased |
4.2% |
| Colitis Ischaemic |
4.2% |
| Electrocardiogram Abnormal |
4.2% |
| Erythema |
4.2% |
| Eye Pain |
4.2% |
| Fatigue |
4.2% |
| Febrile Neutropenia |
4.2% |
| Haemolytic Anaemia |
4.2% |
| Hepatitis Acute |
4.2% |
| Memory Impairment |
4.2% |
| Musculoskeletal Stiffness |
4.2% |
| Overdose |
4.2% |
| Peripheral Sensory Neuropathy |
4.2% |
| Renal Failure |
4.2% |
| Renal Pain |
4.2% |
| Respiratory Depth Decreased |
4.2% |
|
| Secondary |
| Product Used For Unknown Indication |
39.8% |
| Breast Cancer |
14.1% |
| Acute Lymphocytic Leukaemia |
6.5% |
| Chemotherapy |
6.4% |
| Premedication |
4.5% |
| Prophylaxis Of Nausea And Vomiting |
4.4% |
| B-cell Lymphoma |
3.8% |
| Drug Use For Unknown Indication |
2.9% |
| Prophylaxis |
2.6% |
| Large Intestine Carcinoma |
2.2% |
| Pain |
1.7% |
| Pancreatic Neoplasm |
1.7% |
| Vomiting |
1.6% |
| Supplementation Therapy |
1.5% |
| Breast Cancer Recurrent |
1.3% |
| Dyspnoea |
1.1% |
| Thyroid Cancer |
1.1% |
| Ovarian Cancer |
1.0% |
| Pain Management |
1.0% |
| Evidence Based Treatment |
0.9% |
|
| Dyspnoea |
15.3% |
| Fatigue |
9.2% |
| Tachycardia |
7.1% |
| Chest Discomfort |
6.1% |
| Lymphopenia |
6.1% |
| Swollen Tongue |
6.1% |
| Vomiting |
6.1% |
| Musculoskeletal Stiffness |
5.1% |
| Chest Pain |
4.1% |
| Diarrhoea |
4.1% |
| Rash |
4.1% |
| Rash Maculo-papular |
4.1% |
| Anal Abscess |
3.1% |
| Drug Interaction |
3.1% |
| Memory Impairment |
3.1% |
| Neck Pain |
3.1% |
| Photosensitivity Reaction |
3.1% |
| Respiratory Depth Decreased |
3.1% |
| Amnesia |
2.0% |
| Constipation |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.4% |
| Prophylaxis |
17.4% |
| Drug Use For Unknown Indication |
10.0% |
| Breast Cancer |
6.3% |
| Premedication |
6.0% |
| Prophylaxis Of Nausea And Vomiting |
5.2% |
| Nausea |
4.3% |
| Hypertension |
3.6% |
| Colon Cancer |
3.6% |
| Colorectal Cancer |
3.4% |
| Non-small Cell Lung Cancer |
2.8% |
| Pain |
2.5% |
| Colorectal Cancer Metastatic |
2.4% |
| B-cell Lymphoma |
2.3% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Neoplasm Malignant |
2.3% |
| Antiemetic Supportive Care |
2.2% |
| Constipation |
2.2% |
| Gastric Cancer |
2.0% |
| Colon Cancer Metastatic |
1.9% |
|
| Vomiting |
12.3% |
| White Blood Cell Count Decreased |
10.8% |
| Interstitial Lung Disease |
8.7% |
| Sepsis |
7.1% |
| Pneumonia |
6.4% |
| Renal Failure Acute |
5.8% |
| Febrile Neutropenia |
5.4% |
| Thrombocytopenia |
5.4% |
| Pulmonary Embolism |
5.0% |
| Neutropenia |
3.8% |
| Pyrexia |
3.8% |
| Death |
3.7% |
| Nausea |
3.4% |
| Diarrhoea |
3.0% |
| Myocardial Infarction |
2.7% |
| Respiratory Failure |
2.7% |
| Stomatitis |
2.7% |
| Malaise |
2.6% |
| Septic Shock |
2.4% |
| Tachycardia |
2.4% |
|
| Interacting |
| Lymphoma |
34.9% |
| Product Used For Unknown Indication |
32.6% |
| Nausea |
9.3% |
| Pain |
9.3% |
| Chronic Lymphocytic Leukaemia |
7.0% |
| Epilepsy |
7.0% |
|
| Nausea |
42.9% |
| Rash |
28.6% |
| Swelling |
28.6% |
|
